Smith & Nephew SNATS, Inc.
SNN
Positions held
Your positionsSNN isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- Smith & Nephew operates in the growing medical devices industry, which is expected to expand due to increasing healthcare needs and technological advancements.
- The company has a market capitalization of approximately $11.25 billion, indicating a strong position in the healthcare sector.
- Smith & Nephew's revenue is projected to grow to $6.16 billion by 2025, reflecting a positive trend in sales growth.
- The company's current recommendation is to hold, indicating potential caution among analysts regarding future performance.
- Smith & Nephew has a trailing P/E ratio of 18.28, which may suggest that the stock is overvalued compared to its earnings growth.
- The score indicates a 'Sell' signal with a score of -11.00, highlighting negative trends in market performance.
Fundamentals
| Market cap | $11.28B | Enterprise value | $60.40B | Trailing P/E | 18.34 | Forward P/E | 11.18 |
| PEG | 1.03 | Price / book | 11.07 | Beta | 0.67 | Dividend yield | 2.95% |
| Revenue growth | 4.6% | Earnings growth | 5.7% | Gross margin | 68.4% | Operating margin | 14.5% |
| Profit margin | 10.1% | ROE | 11.9% | ROA | 5.2% | Debt / equity | 0.73 |
| Current ratio | 2.14 | Free cash flow | $1.06B | Analyst recommendation | hold | Mean target | $32.32 |
| 52w high | $37.51 | 52w low | $26.12 |
Quarterly
No data yet.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $6.2B | $5.8B | $5.5B | $5.2B | — |
| Op margin | 13.9% | 14.8% | 11.2% | 12.2% | — |
| Net income | $625M | $412M | $263M | $223M | — |
| Gross margin | 68.0% | 69.6% | 68.8% | 70.5% | — |
| Gross profit | $4.2B | $4.0B | $3.8B | $3.7B | — |
| Operating income | $857M | $860M | $620M | $634M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · Smith+Nephew Launches CARTIHEAL Implant Across Key European Markets
2026-10-07 · Howden Joinery Group Plus 2 British Undervalued Stocks To Watch
2026-10-06 · Smith & Nephew Launches CartiHeal Cartilage Repair Implant in Europe
2026-10-02 · Smith & Nephew PLC's Dividend Analysis
2026-10-01 · Owens & Minor Names Carrie Childress Its First Chief Marketing Officer in Company History
2026-10-01 · GS adds four European stocks to conviction list as earnings catalysts emerge
2026-09-30 · Smith+Nephew Launches EVOS PELVIC System to Advance Trauma Care
Price (daily)
Full chart · RSI · MACD · patterns